InvestorsHub Logo
Followers 1322
Posts 247512
Boards Moderated 56
Alias Born 12/07/2009

Re: Kbro13 post# 31670

Monday, 12/04/2017 8:47:09 AM

Monday, December 04, 2017 8:47:09 AM

Post# of 118365
$RGBP Regen BioPharma, Inc. (OTCQB: RGBP) announced breaking news after the market close that it has, "commenced a program to identify small molecules that inhibit the NR2F6 nuclear receptor. The NR2F6 nuclear receptor has been identified as a potentially very important immune cell inhibitor (an immune checkpoint) and cancer stem cell differentiator. Biotechnology and Oncology Markets Have Positive Projections http://prn.to/2ARQPN8


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.